{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:50:12Z","timestamp":1760237412791,"version":"build-2065373602"},"reference-count":55,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["18-08-00444"],"award-info":[{"award-number":["18-08-00444"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>The treatment of classical phenylketonuria is currently represented by many new methods of disease management. A promising method is the use of the enzyme L-phenylalanine ammonia-lyase (PAL) in various forms. The widespread use of enzyme preparations in therapy is limited by a lack of understanding of the mechanisms and systems of the targeted transport of PAL into certain organs and tissues as a result of the incorporation of a drug into the carrier. To ensure the stability of enzymes during the delivery process, encapsulation is preferable, which, as a rule, ensures the preservation of the qualitative characteristics of the enzymes orally applied to the environmental effects of the gastrointestinal tract (acidity, temperature, oxidation, etc.). Capsule preparations showed sufficient stability in the model gastric fluids and sustained release of the drug in the simulated intestinal fluid. Currently, there is a wide range of polymers used for encapsulation. The use of natural sources in the production technology of capsule systems improves bioavailability, controls the release, and prolongs the half-life of active substances. The advantage of this method is that the used enzyme is completely protected by the cell membranes of the capsules, which preserve its stability in the aggressive environment of the gastrointestinal tract. Capsules were obtained on the basis of compositions of hydrocolloids of plant origin. The potential of the developed capsules for targeted delivery of the enzyme preparation was studied. The degradation of the encapsulated form of the PAL enzyme preparation was studied in vitro in model bio-relevant media simulating the gastric and intestinal environment. The dynamics of the breakdown of the capsule shell allow us to expect that the release of L-phenylalanine ammonia-lyase from capsules based on plant hydrocolloids will occur no earlier than reaching the upper intestines, where the interaction with the protein components of the consumed food products to neutralize phenylalanine should occur.<\/jats:p>","DOI":"10.3390\/ph13040063","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T14:42:03Z","timestamp":1586443323000},"page":"63","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Study of the Potential of the Capsule Shell Based on Natural Polysaccharides in Targeted Delivery of the L-Phenylalanine Ammonia-Lyase Enzyme Preparation"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4921-8997","authenticated-orcid":false,"given":"Olga","family":"Babich","sequence":"first","affiliation":[{"name":"Institute of Living Systems, Immanuel Kant Baltic Federal University, A. Nevskogo Street 14, Kaliningrad 236016, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7333-8411","authenticated-orcid":false,"given":"Lyubov","family":"Dyshlyuk","sequence":"additional","affiliation":[{"name":"Research Institute of Biotechnology, Kemerovo State University, Krasnaya Street 6, Kemerovo 650043, Russia"},{"name":"Natural Nutraceutical Biotesting Laboratory, Kemerovo State University, Krasnaya Street 6, Kemerovo 650043, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5630-3196","authenticated-orcid":false,"given":"Alexander","family":"Prosekov","sequence":"additional","affiliation":[{"name":"Laboratory of Biocatalysis, Kemerovo State University, Krasnaya Street 6, Kemerovo 650043, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Noskova","sequence":"additional","affiliation":[{"name":"Institute of Living Systems, Immanuel Kant Baltic Federal University, A. Nevskogo Street 14, Kaliningrad 236016, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oksana","family":"Ivina","sequence":"additional","affiliation":[{"name":"Department of Information and Automated Production Systems, T.F. Gorbachev Kuzbass State Technical University, Vesenyaya Street, 28, Kemerovo 650000, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9460-7126","authenticated-orcid":false,"given":"Valery","family":"Pavsky","sequence":"additional","affiliation":[{"name":"Research Institute of Biotechnology, Kemerovo State University, Krasnaya Street 6, Kemerovo 650043, Russia"},{"name":"Department of General Mathematics and Informatics, Kemerovo State University, Krasnaya Street, 6, Kemerovo 650043, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1252-9572","authenticated-orcid":false,"given":"Svetlana","family":"Ivanova","sequence":"additional","affiliation":[{"name":"Natural Nutraceutical Biotesting Laboratory, Kemerovo State University, Krasnaya Street 6, Kemerovo 650043, Russia"},{"name":"Department of General Mathematics and Informatics, Kemerovo State University, Krasnaya Street, 6, Kemerovo 650043, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Bulgakova","sequence":"additional","affiliation":[{"name":"Department of General Mathematics and Informatics, Kemerovo State University, Krasnaya Street, 6, Kemerovo 650043, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40265-019-01079-z","article-title":"Phenylketonuria: Current treatments and future developments","volume":"79","author":"Vockley","year":"2019","journal-title":"Drugs"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ymgme.2011.08.009","article-title":"Up to date knowledge on different treatment strategies for phenylketonuria","volume":"104","author":"Burlina","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(80)90944-7","article-title":"Enzymatic control of phenylalanine intake in phenylketonuria","volume":"315","author":"Hoskins","year":"1980","journal-title":"Lancet"},{"key":"ref_4","first-page":"253","article-title":"Intake and blood levels of fatty acids in treated patients with phenylketonuria","volume":"33","author":"Acosta","year":"2001","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0002-8223(03)00983-0","article-title":"Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy","volume":"103","author":"Acosta","year":"2003","journal-title":"J. Am. Diet. Assoc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.GIM.0000117335.50541.F3","article-title":"Iron status of children with phenylketonuria undergoing nutrition therapy assessed by transferrin receptors","volume":"6","author":"Yannicelli","year":"2004","journal-title":"Genet. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s10545-007-0462-9","article-title":"Peak bone mass in patients with phenylketonuria","volume":"30","author":"Vered","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","article-title":"The complete European guidelines on phenylketonuria: Diagnosis and treatment","volume":"12","author":"MacDonald","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_9","first-page":"16","article-title":"Investigation of kinetic aspects of L-phenylanine ammonia-lyase production in pigmental yeast","volume":"33","author":"Babich","year":"2015","journal-title":"Chim. Oggi Chem. Today"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/bab.1089","article-title":"Recombinant l-phenylalanine ammonia lyase from Rhodosporidium toruloides as a potential anticancer agent","volume":"60","author":"Babich","year":"2013","journal-title":"Biotechnol. Appl. Biochem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.12737\/5464","article-title":"Screening and identification of pigmental yeast producing L-phenylalanine ammonia-lyase and their physiological and biochemical characteristics","volume":"2","author":"Babich","year":"2014","journal-title":"Foods Raw Mater."},{"key":"ref_12","first-page":"48","article-title":"Expression of recombinant L-phenylalanine ammonia-lyase in Escherichia coli","volume":"1","author":"Babich","year":"2013","journal-title":"Foods Raw Mater."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ymgme.2018.06.002","article-title":"Phenylalanine ammonia lyase (PAL): From discovery to enzyme substitution therapy for phenylketonuria","volume":"124","author":"Levy","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1073\/pnas.96.5.2339","article-title":"A different approach to treatment of phenylketonuria: Phenylalanine degradation with recombinant phenylalanine ammonia lyase","volume":"96","author":"Sarkissian","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/nsb1297-995","article-title":"Crystal structure of the catalytic domain of human phenylalanine hydroxylase reveals the structural basis for phenylketonuria","volume":"4","author":"Erlandsen","year":"1997","journal-title":"Nat. Struct. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(13)61841-3","article-title":"Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: An open-label, multicentre, phase 1 dose-escalation trial","volume":"384","author":"Longo","year":"2014","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.12737\/4117","article-title":"Studying the biokinetics of pigmented yeast by stochastic methods","volume":"2","author":"Ivanova","year":"2014","journal-title":"Foods Raw Mater."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"682","DOI":"10.18097\/pbmc20135906682","article-title":"Optimization of L-phenylalanine-ammonia-lyase lyophilization","volume":"59","author":"Babich","year":"2013","journal-title":"Biomeditsinskaya Khimiya"},{"key":"ref_19","unstructured":"Orndorff, S.A., and Durham, D.R. (1988). Phenylalanine Ammonia Lyase-Producing Strains. (No. 4757015), U.S. Patent."},{"key":"ref_20","unstructured":"McGuire, J.C., Montgomery, J.P., and Yang, H.H. (1987). Phenylalanine Ammonia Lyase-Producing Microbial Cells. (No. 4636466), U.S. Patent."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.12737\/2056","article-title":"Study of physicochemical and thermal properties of l-phenylalanine ammonia-lyase","volume":"1","author":"Babich","year":"2013","journal-title":"Foods Raw Mater."},{"key":"ref_22","unstructured":"Li, Q., and K\u00e4mpe, O. (2018). Recombinant Phe-Free Proteins for Use in the Treatment of Phenylketonuria. (No. 15512974), U.S. Patent."},{"key":"ref_23","first-page":"1455","article-title":"Effect of lyophilization conditions of recombinant L-phenylalanine-ammonia-lyase on enzyme properties","volume":"15","author":"Babich","year":"2013","journal-title":"Middle East J. Sci. Res."},{"key":"ref_24","unstructured":"Eigtved, P., and Clausen, I.G. (1998). Stabilised Phenylalanine Ammonia Lyase. (No. 5753487), U.S. Patent."},{"key":"ref_25","unstructured":"Kishore, G.M. (1985). Stabilization of L-Phenylalanine Ammonia-Lyase Enzyme. (No. 4562151), U.S. Patent."},{"key":"ref_26","unstructured":"Vellard, M.C., Fitzpatrick, P.A., and Kakkis, E.D. (2009). Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof. (No. 7531341), U.S. Patent."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1042\/bj1990715","article-title":"The effect of proteinases on phenylalanine ammonia-lyase from the yeast Rhodotorula glutinis","volume":"199","author":"Gilbert","year":"1981","journal-title":"Biochem. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0006-291X(85)91272-0","article-title":"Protection of phenylalanine ammonia-lyase from proteolytic attack","volume":"131","author":"Gilbert","year":"1985","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"20894","DOI":"10.1073\/pnas.0808421105","article-title":"Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria","volume":"105","author":"Sarkissian","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","unstructured":"Galle, M., Gregory, P.-C., Potthoff, A., and Hennines, F. (2004). Microbial Enzyme Mixtures Useful to Treat Digestive Disorders. (Application No. 20040057944), U.S. Patent."},{"key":"ref_31","unstructured":"Sipos, T. (1998). High Buffer-Containing Enteric Coating Digestive Enzyme Bile Acid Compositions and Method of Treating Digestive Disorders Therewith. (No. 5,750,104), U.S. Patent."},{"key":"ref_32","unstructured":"Sipos, T. (1978). Preparation of Enteric Coated Digestive Enzyme Compositions. (Application No. 4379125), U.S. Patent."},{"key":"ref_33","unstructured":"Sipos, T. (1994). Compositions of Digestive Enzymes and Salts of Bile Acids and Process For Preparation Thereof. (No. 5,324,514), U.S. Patent."},{"key":"ref_34","unstructured":"Bilton, G.L. (1984). Enzyme-Containing Digestive Aid Compostions. (No. 4,447,412), U.S. Patent."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1039\/C6SC04650A","article-title":"Near-IR-induced dissociation of thermally-sensitive star polymers","volume":"8","author":"Dai","year":"2017","journal-title":"Chem. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"17048","DOI":"10.1002\/anie.201809753","article-title":"Self-Assembled Aptamer-Grafted Hyperbranched Polymer Nanocarrier for Targeted and Photoresponsive Drug Deliver","volume":"57","author":"Yang","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"17359","DOI":"10.1002\/anie.201908634","article-title":"Bioactive Peptide Brush Polymers via Photoinduced Reversible-Deactivation Radical Polymerization","volume":"58","author":"Sun","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.colsurfb.2004.10.032","article-title":"Microencapsulation peptide and protein drugs delivery system","volume":"41","author":"Dai","year":"2005","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.supflu.2008.08.015","article-title":"Encapsulation and co-precipitation processes with supercritical fluids: Fundamentals and applications","volume":"47","author":"Cocero","year":"2009","journal-title":"J. Supercrit. Fluids"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"10606","DOI":"10.1002\/anie.201904549","article-title":"Encapsulation of a Phase-Change Material in Nanocapsules with a Well-Defined Hole in the Wall for the Controlled Release of Drugs","volume":"58","author":"Qiu","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ijpharm.2019.06.016","article-title":"Elucidating molecular properties of kappa-carrageenan as critical material attributes contributing to drug dissolution from pellets with a multivariate approach","volume":"566","author":"Horvat","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cofs.2015.04.001","article-title":"The parallel lives of polysaccharides in food and pharmaceutical formulations","volume":"4","author":"Kontogiorgos","year":"2015","journal-title":"Curr. Opin. Food Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2014.08.004","article-title":"Pre-systemic metabolism of orally administered drugs and strategies to overcome it","volume":"192","year":"2014","journal-title":"J. Control Release"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1038\/s41598-020-60463-y","article-title":"A microparticulate based formulation to protect therapeutic enzymes from proteolytic digestion: Phenylalanine ammonia lyase as case study","volume":"10","author":"Gourmel","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1002\/jbm.a.36739","article-title":"Recent progress in preparation and agricultural application of microcapsules","volume":"107","author":"Li","year":"2019","journal-title":"J. Biomed. Mater. Res. A"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e03096","DOI":"10.1016\/j.heliyon.2019.e03096","article-title":"The effectiveness of plant hydrocolloids at maintaining the quality characteristics of the encapsulated form of L-phenylalanine-ammonia-lyase","volume":"6","author":"Babich","year":"2020","journal-title":"Heliyon"},{"key":"ref_47","unstructured":"OFS.1.2.4.0002.15 (2016). Mikrobiologicheskaya Chistota [OFS.1.2.4.0002.15 Microbiological Purity], (In Russian)."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.btre.2014.12.012","article-title":"Efficient utilisation of hydrogel preparations with encapsulated enzymes\u2013a case study on catalase and hydrogen peroxide degradation","volume":"6","author":"Noworyta","year":"2015","journal-title":"Biotechnol. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejps.2019.01.012","article-title":"Characterization of the gastrointestinal transit and disintegration behavior of floating and sinking acid-resistant capsules using a novel MRI labeling technique","volume":"129","author":"Grimm","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejpb.2009.07.007","article-title":"Magnetic marker monitoring: High resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract","volume":"74","author":"Weitschies","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jddst.2017.12.020","article-title":"Role of plasticizer in membrane coated extended release oral drug delivery system","volume":"44","author":"Khatri","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_52","unstructured":"Qiu, Y., Chen, Y., Zhang, G.G.Z., Yu, L., and Mantri, R.V. (2017). Capsules dosage form: Formulation and manufacturing considerations. Developing Solid Oral Dosage Forms. Pharmaceutical Theory and Practice, Academic Press."},{"key":"ref_53","first-page":"2","article-title":"The Chemical Resistance of Capsule Shells Based on Vegetable Analog of Pharmaceutical Gelatin","volume":"7","author":"Prosekov","year":"2015","journal-title":"Biol. Med."},{"key":"ref_54","unstructured":"Dyshlyuk, L.S., Asyakina, L.K., and Babich, O.O. (2014, January 28). Studying of structure and properties of sodium alginate for obtaining biodegraded polymer materials. Proceedings of the 3rd European Conference on Biology and Medical Sciences, Vienna, Austrian."},{"key":"ref_55","first-page":"2","article-title":"Physical and Chemical Properties of Capsule Shell Based on Plant Analogues of Pharmaceutical Gelatin","volume":"7","author":"Prosekov","year":"2015","journal-title":"Biol. Med."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/13\/4\/63\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:16:55Z","timestamp":1760174215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/13\/4\/63"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,9]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["ph13040063"],"URL":"https:\/\/doi.org\/10.3390\/ph13040063","relation":{},"ISSN":["1424-8247"],"issn-type":[{"type":"electronic","value":"1424-8247"}],"subject":[],"published":{"date-parts":[[2020,4,9]]}}}